Orchard Rx Ltd. ORTX 深 滬
等待開盤 10-29 09:30:00 美东时间
16.70
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 16.70
- 總市值 3.80亿
- 52周最高 16.72
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.24
- 委 比 0.00%
- 總股本 2272.72万
- 歷史最高 216.40
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.601
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2...
10-21 20:27
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Shares of Delcath Systems Inc (NASDAQ:DCTH) rose sharply in pre-market trading ...
10-20 17:10
XORTX Expands Kidney Disease Pipeline With $3M Acquisition Of Vectus' VB4-P5 Therapeutic Program
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
10-17 19:10
Vectus Biosystems Sells Renal Compound to XORTX Therapeutics
The latest update is out from Vectus Biosystems Limited ( ($AU:VBS) ). Vectus B...
10-17 16:18
XORTX Therapeutics Initiates IND Preparation For XRx-026, Focused On Treatment Of Gout
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
09-03 19:09
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therap...
08-09 08:38
XORTX Therapeutics Completes US$925,000 Private Placement to Fund Gout Programs
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therap...
07-23 08:32
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) rose sharply in today's pre-m...
07-07 18:26
XORTX Therapeutics Announces Non-Brokered Private Placement To Raise Up To $925K Through Issuance Of Up To 1.27M Common Share Units At $0.73/Unit
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
06-26 19:14
